Market cap
$106.600 M
$2.05 +1.49%
Close of 7 Aug 2026
Revenue
$917.0K
#3507 by revenue
Earnings
-$30.5M
Loss-making
Shares outstanding
—
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Rafael are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.